GE has improved its financial position significantly since then. It netted $13 billion between 2018 and 2019 from selling parts of its industrial businesses. GE Capital generated nearly $6 billion of proceeds from asset sales over the same period. In March 2020, GE closed its biggest disposition of all, selling its biopharma unit to Danaher for net cash proceeds of approximately $20 billion.